LDR Announces Six Podium Presentations Regarding The Mobi-C® Cervical Disc Were Delivered At The International Society For The Advancement Of Spine Surgery 2014 Annual Meeting

Published: May 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Austin, TX, May 5, 2014 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq: LDRH), a global medical device company focused on designing and commercializing novel and exclusive device technologies for the treatment of patients suffering from spine disorders, announced today that six presentations were delivered on the Mobi-C Cervical Disc (Mobi-C) at the 2014 International Society for the Advancement of Spine Surgery (ISASS) meeting. The presentations highlighted the results of the Mobi-C one and two-level Investigational Device Exemption (IDE) clinical trial. The presentations provided patient outcomes up to 48-month follow-up, and represent the most Mobi-C results presented at any one given venue to date.

Help employers find you! Check out all the jobs and post your resume.

Back to news